Circulating endothelin-1 levels in obese patients with the metabolic syndrome

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue SUPPL. 2, 1997, Pages 38-40

  Ferri, Claudio ^a   Bellini, Cesare ^c   Desideri, Giovambattista ^a   Baldoncini, Roberta ^a   Properzi, Giuliana ^b   Santucci, Anna ^b   De Mattia, Giancarlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Endothelins; Glucose; Insulin; Lipids

Indexed keywords

ENDOTHELIN 1; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; VENOUS BLOOD;

EID: 0030869738     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211794     Document Type: Article

References (23)

1. Alessi MC, Juan-Vague I, Kooistra T, DeClerk PJ, Collen D: Insulin stimulates the synthesis of plasminogen activator inhibitor I. Thromb Haemostas, 60:491-494, 1988
2. Canessa M, Adragna N, Solomon HS, Connolly B, Tosteson DC: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Eng J Med, 302:772- 776, 1980
3. Carr SJ, Thomas TH, Laker MF, Wilkinson R: Elevated sodium-lithium countertransport: a familial marker of hyperlipidaemia and hypertension ? J Hypertens, 8:139-146, 1990
4. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atheroslcerotic heart disease. Diabetes Care, 14:173-194, 1991
5. Doria A, Fioretto P, Avogaro A: Insulin resistance is associated with high sodium/lithium countertransport in essential hypertension. Am J Physiol, 261:E684-E691, 1991
6. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone Faldetta R, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab, 80:829-835, 1995a
7. Ferri C, Bellini C, Desideri GB, Di Francesco L, Baldoncini R, Santucci A, De Mattia G: Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes, 44:431-436, 1995b
8. Ferri C, Carlomagno A, Baldoncini R, Cassone R, Laurenti O, Properzi G, Santucci A, De Mattia G: Circulating endothelin-1 levels increase during euglycaemic hyperinsulinaemic clamp in NIDDM men. Diabetes Care, 18:226-233, 1995c
9. Ferri C, Properzi G, Santucci A: Endothelin-1: a pathogenic factor in human disease or a physiologistís curiosity. High Blood Press, 4:1-19, 1995d
10. Hamet P, Sugimoto H, Humeda L, Lecavalier L, Franks DJ, Orth DN: Abnormalities of platelet-derived growth factors in insulin dependent diabetes. Metabolism, 34 (Suppl 1); 25-31, 1985
11. Hattori Y, Kasai K, Makamura T, Emoto T, Shimoda S: Effects of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism, 40(2):165-169, 1991
12. Hu R, Levin ER, Pedram A, Frank HJL: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes, 42:351-358, 1993
13. Morgan DB, Stewart AD, Davidson C: Relations between erythrocyte lithium efflux, blood pressure and family histories of hypertension and cardiovascular disease: studies in a factory workforce and hypertension clinic. J Hypertens, 4:609-615, 1986
14. Nosadini R, Semplicini A, Fioretto P, Lusiani L, Trevisan R, Donadon V, Zanette G, Nicolosi GL, Dall'Aglio V, Zanuttini D, Viberti GC: Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension. Hypertension, 18:191-198, 1991
15. Pfeile B, Dischainet H: Effect of insulin on growth of human arterial smooth muscle cells. Diabetologia, 20:155-158, 1981
16. Reaven GM: Role of insulin resistance in human disease: Banting Lecture 1988. Diabetes, 37:1595-1607, 1988
17. Rowe JW, Young JB, Mimaker KL, Stevens AL, Pallotta J, Landsberg L: Effects of insulin and glucose infusions on sympathetic nervous system activity in man. Diabetes, 30:219-225, 1981
18. Santucci A, Ferri C: Insulin resistance and essential hypertension: pathophysiologic and therapeutic implications. J Hypertens, 10(Suppl2):S9-S15, 1992
19. Stern MP, Morales PA, Haffner SM, Valdez RA: Hyperdynamic circulation and the insulin resistance syndrome (Syndrome X). Hypertension, 20:802-808, 1992
20. Takahashi K, Gathei MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia, 33:306-310, 1990
21. Tedde R, Sechi LA, Marigliano A, Pala A: In vitro actions of insulin on erythrocyte sodium transport mechanisms: its possible role in the pathogenesis of arterial hypertension. Clin Exp Ther Pract, 4:545-559, 1988
22. Wolpert HA, Steen SN, Istfan NW, Simonson DC: Insulin modulates circulating endothelin-1 levels in humans. Metabolism, 8:1027-1030, 1993
23. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332:411-415, 1988